Valuation: EUROAPI

Market Cap 61.33M 67.34M 56.51M 51.4M 96.44M 6.24B 101M 688M 273M 3.41B 253M 247M 10.69B P/E 2026 *
-0.49x
P/E 2027 * -1.14x
Enterprise Value 117M 128M 107M 97.7M 183M 11.85B 193M 1.31B 520M 6.47B 480M 470M 20.31B EV / Sales 2026 *
0.16x
EV / Sales 2027 * 0.22x
Free-Float
64.75%
Yield 2026 *
-
Yield 2027 * -
1 day-5.87%
1 week-11.81%
Current month-22.18%
1 month-15.75%
3 months-34.42%
6 months-55.72%
Current year-71.72%
1 week 0.63
Extreme 0.629
0.73
1 month 0.63
Extreme 0.629
0.84
Current year 0.63
Extreme 0.629
2.28
1 year 0.63
Extreme 0.629
3.28
3 years 0.63
Extreme 0.629
7.02
5 years 0.63
Extreme 0.629
19.02
10 years 0.63
Extreme 0.629
19.02
Manager TitleAgeSince
Chief Executive Officer - 2024-12-08
Director of Finance/CFO - 2024-10-16
Compliance Officer - 2023-11-26
Director TitleAgeSince
Director/Board Member 62 2022-05-05
Director/Board Member - 2022-05-05
Chairman 57 2024-12-08
Date Insider Type Main position Quantity % Market Cap. Importance
6/1/23 Buy

Chief Financial Officer

617 0.0007%
6/1/23 Buy

Chief Financial Officer

620 0.0007%
6/1/23 Buy

Chief Financial Officer

617 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
-5.87%-11.81%-79.49%-87.51% 67.34M
-0.30%-6.68%+27.12%+127.32% 1,200B
+1.25%-5.35%+32.65%+78.98% 651B
+0.94%-2.99%+21.13%+106.30% 506B
-0.60%-1.95%+25.73%+67.00% 377B
+0.69%-9.50%+36.78%+30.83% 330B
+0.41%-4.70%+24.18%+50.18% 288B
+0.81%-4.08%-2.95%+31.59% 272B
-0.15%-6.45%+29.06%+65.76% 236B
-0.06%-0.98%+31.42%+122.83% 206B
Average -0.29%-5.46%+14.56%+59.33% 407B
Weighted average by Cap. +0.30%-5.19%+26.02%+87.87%

Financials

2026 *2027 *
Net sales 748M 822M 689M 627M 1.18B 76.07B 1.24B 8.39B 3.34B 41.55B 3.08B 3.02B 130B 748M 821M 689M 627M 1.18B 76B 1.24B 8.38B 3.33B 41.51B 3.08B 3.01B 130B
Net income -125M -137M -115M -104M -196M -12.66B -206M -1.4B -555M -6.91B -513M -502M -21.7B -53.63M -58.88M -49.42M -44.95M -84.33M -5.45B -88.63M -601M -239M -2.98B -221M -216M -9.35B
Net Debt 55.24M 60.64M 50.9M 46.3M 86.85M 5.62B 91.28M 619M 246M 3.07B 228M 223M 9.63B 105M 115M 96.6M 87.87M 165M 10.66B 173M 1.18B 467M 5.82B 432M 423M 18.27B
Projected Income Statement - Annual - EUROAPI
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Date Price Change Volume
26-11-20 €0.6420 -5.87% 226,839
26-11-19 €0.6820 -2.43% 55,875
26-11-18 €0.6990 +0.14% 182,184
26-11-17 €0.6980 -3.06% 236,095
26-11-16 €0.7200 -1.10% 641,865
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - EUROAPI
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
4
Last Close Price
0.6420EUR
Average target price
1.000EUR
Spread / Average Target
+55.76%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - EUROAPI
  1. Stock Market
  2. Stocks
  3. EAPI Stock